MedCity News January 26, 2020
SVB’s healthcare investment report for 2019 found that Series A investment in platform technology exceeded oncology, which had led since 2013. The report forecast a 10-15% decrease in overall biopharma investment for 2020.
Last week’s J.P. Morgan Healthcare Conference was generally seen as slower than usual, perhaps because of the lack of major acquisition deals that characterized the 2019 healthcare industry confab. Nevertheless, a new report on the state of investing and fundraising in the healthcare industry shows things are still chugging along.
The report, from Santa Clara, California-based Silicon Valley Bank, found that while 2019’s total $32 billion investment in biopharma, diagnostics and tools, devices and healthcare was slightly below the record set in 2018, it was still well...
Today's Sponsors
Today's Sponsor